Agios Pharmaceuticals AGIO
NASDAQ AGIO
$37.00 -0.19 (-0.51%)
At close: Oct 23, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Cash & Current Investments (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) recorded Cash & Current Investments of $617.58 million in Q2 2026, down 34.2% from $938.94 million a year earlier and down 16.2% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Cash & Current Investments (2012 - 2026) Analysis & Trends

At the end of FY2025, Agios Pharmaceuticals reported Cash & Current Investments of $854.43 million, down 4.4% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $893.71 million in FY2024 (+15.0%), $776.93 million in FY2023 (-0.8%), $783.12 million in FY2022 (-23.2%) and $1.02 billion in FY2021 (+78.0%).
  • The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q2 2024.
  • On a year-over-year basis, Cash & Current Investments has declined for four consecutive quarters, with growth averaging 15.4% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 109.1% in Q3 2021, against a decline of 60.5% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $737.04 million (Q1 2026), $854.43 million (Q4 2025) and $952.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Agios Pharmaceuticals 2.21 Bn -950.70 Mn 41.75 Mn 617.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 617.58 Mn
Mar 31, 2026 737.04 Mn
Dec 31, 2025 854.43 Mn
Sep 30, 2025 952.86 Mn
Jun 30, 2025 938.94 Mn
Mar 31, 2025 893.38 Mn
Dec 31, 2024 893.71 Mn
Sep 30, 2024 1.00 Bn
Jun 30, 2024 569.89 Mn
Mar 31, 2024 597.99 Mn
Dec 31, 2023 776.93 Mn
Sep 30, 2023 647.49 Mn
Jun 30, 2023 702.57 Mn
Mar 31, 2023 739.20 Mn
Dec 31, 2022 783.12 Mn
Sep 30, 2022 727.68 Mn
Jun 30, 2022 819.31 Mn
Mar 31, 2022 923.53 Mn
Dec 31, 2021 1.02 Bn
Sep 30, 2021 1.27 Bn
API Access

Agios Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AGIO&period=max&api_key=YOUR_API_KEY